ACOTIAMIDE 100mg. IP

A novel oral gastroprokinetic agent that increases the movement of food in the stomach and intestines. (Ege Altan, 2012) A first-in-class drug developed for the treatment of functional dyspepsia and other upper gastrointestinal symptomatic conditions. (Kei Matsueda, 2012) A selective acetylcholinesterase inhibitor that enhances the actions of cholinergic neurons localized in the stomach. (K. Matsueda, 2010) Efficient in relieving functional dyspepsia symptoms, especially post-meal fullness, upper abdominal bloating, and early satiation. (Ege Altan, 2012) Significantly increases gastric accommodation, gastric emptying, and improves dyspeptic symptoms in patients with functional dyspepsia. (Kumiko Nakamura, 2016) Exerts a higher rate of elimination of meal-related functional dyspepsia symptoms. (Kei Matsueda, 2012) A safe, effective, and well-tolerated candidate for the treatment of patients with postprandial distress syndrome. (Kei Matsueda, 2012)